Glimestar-PM1 Tablet ER

Glimestar-PM1 Tablet ER
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Glyzee PM1 Tablet ER
Zeelab Pharmacy Pvt Ltd
Pioglitazone 15mgPack Size
1 units
Price
Save ₹58
that's 71% off!
About This Medicine
Product description & overview
Glimestar-PM1 Tablet ER: Comprehensive Diabetes Management
Glimestar-PM1 is a once-daily extended-release tablet formulation designed for managing type 2 diabetes mellitus. Combining three key medications – glimepiride (1mg), metformin (500mg), and pioglitazone (15mg) – this unique formula offers comprehensive blood sugar control.
Glimepiride stimulates insulin release from the pancreas, improving glucose uptake by muscle cells. Metformin lowers blood glucose levels through multiple mechanisms like reducing hepatic glucose production and enhancing insulin sensitivity. Pioglitazone, a thiazolidinedione derivative, promotes glucose uptake in peripheral tissues, further contributing to blood sugar control.
Glimestar-PM1 delivers precise doses of these medications for efficient and sustained glycemic management. This formulation ensures consistent efficacy throughout the day, promoting patient compliance and convenient dosing.
Important: Consult with a healthcare professional before starting any new medication regimen. This product is not suitable for all individuals and may interact with certain drugs or conditions.
Active composition
Glimepiride 1 mg
+2 more active ingredients
About Glimepiride
Glimepiride is an oral hypoglycemic agent used to manage blood sugar levels in patients with type 2 diabetes mellitus. It works by stimulating the pancreas to release more insulin, thereby lowering blood glucose levels and preventing the symptoms associated with diabetes. Glimepiride is often prescribed alongside diet and exercise to enhance glycemic control and reduce the risk of diabetes-related complications, such as kidney damage and neuropathy. In summary, Glimepiride is an essential medication for controlling blood sugar levels in type 2 diabetes patients.
How It Works
Glimepiride stimulates insulin secretion from pancreatic beta cells and enhances insulin sensitivity in peripheral tissues, facilitating glucose uptake and lowering blood sugar levels.
All Active Ingredients
Pioglitazone
Pioglitazone activates peroxisome proliferator-activated receptor gamma (PPAR-γ), enhancing insulin sensitivity and glucose metabolism.
Metformin
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
Dosage & How to Use
Dosage information not available. Please consult your doctor or pharmacist.
Safety Advice
Important precautions
Side Effect Occurrence
Based on clinical trials and patient reports.
Overall Tolerance
Most patients tolerate well
Common Side Effects
Safety Advice
Alcohol
It is unsafe to consume alcohol with Glimestar-PM1 Tablet ER.
High Risk
Pregnancy
Glimestar-PM1 Tablet ER may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Medical Advice
Driving
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Exercise Caution
Liver
Glimestar-PM1 Tablet ER should be used with caution in patients with liver disease. Dose adjustment of Glimestar-PM1 Tablet ER may be needed. Please consult your doctor. Use of Glimestar-PM1 Tablet ER is not recommended in patients with severe liver disease.
Regular Checkup
Breastfeeding
Glimestar-PM1 Tablet ER is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Consult Doctor
Kidney
Glimestar-PM1 Tablet ER should be used with caution in patients with kidney disease. Dose adjustment of Glimestar-PM1 Tablet ER may be needed. Please consult your doctor. Use of Glimestar-PM1 Tablet ER is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.
Regular Checkup
Customer Reviews
0 reviews for Glimestar-PM1 Tablet ER
Products matching your search

Olmezest H 20 Tablet

Olmezest H 20 Tablet

Grinednox-L Capsule

Grinednox-L Capsule

Losanorm 50-H Tablet

Losanorm 50-H Tablet

Glimchek M 2mg/500mg Tablet

Glimchek M 2mg/500mg Tablet

Carispec 6 Capsule

Carispec 6 Capsule

Flunasys-P Tablet SR

Flunasys-P Tablet SR

Calzol-D3 Tablet

Calzol-D3 Tablet

Glz Total Tablet
